Acasti Pharma Inc. (ACST) has an overall financial health rating of C+ with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-10-25.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2024-10-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-22 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-15 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-10-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
